Study: Medical-Only Cannabis Users in California Show Distinct Patterns Compared to Combined Users

A new study from researchers at the University of California San Diego highlights key differences between people who use cannabis solely for medicinal reasons and those who use it for both medicinal and recreational purposes following the enactment of California’s Proposition 64.

The findings, published in the Journal of Cannabis Research, are based on survey responses from over 4,000 current cannabis users as part of a broader population-matched study. Of those respondents, 711 identified as using marijuana strictly for medical reasons, while 1,719 reported using it for both medical and recreational purposes.

Medicinal-only users were more likely to be female, start using cannabis later in life, and live in households with children. Their average age of first use was 34, compared to 23 among combined users. They also reported spending less on cannabis—$127 per month versus $186—and using it less frequently. Only 25% of medicinal-only users consumed cannabis multiple times per day, compared to nearly half of combined users.

Pain relief was the most cited reason for using cannabis among medicinal-only participants, followed by help with sleep, anxiety, and stress. While both groups reported mental health benefits, medicinal-only users were more likely to cite relief from physical symptoms, whereas combined users were more likely to report emotional or psychological benefits.

Despite their therapeutic focus, medicinal-only users were less comfortable discussing cannabis use with their doctors than combined users. Only 75% felt comfortable talking to their primary care provider about their marijuana use, compared to 83% of those in the combined-use group. Still, most believed their doctors were supportive of medical cannabis use.

Both groups were more likely to seek cannabis-related information online or from friends and family rather than from health professionals. Just 26–27% of respondents in either group said they consulted a clinician about marijuana use.

Licensed dispensaries were the primary source of cannabis for both user groups, though medicinal-only users placed more emphasis on buying from licensed retailers. While 72% of medicinal-only users said purchasing from a licensed dispensary was very or extremely important, only 66% of combined users said the same.

The study also examined driving behavior. Medicinal-only users were far more cautious, frequently reporting that they waited until the next day to drive after using cannabis, whereas many combined users reported waiting less than an hour.

When it came to side effects, combined users reported more frequent adverse effects such as paranoia, memory loss, fatigue, and lack of motivation. These users were also more likely to have started using cannabis before the age of 17—a factor linked to increased risks of dependency and negative outcomes.

The study’s authors emphasize the need for better communication between patients and providers and more consistent guidance on safe and effective medicinal cannabis use. They also highlight that while combined users may share similar motivations for cannabis use, their behavior, attitudes, and risks differ in meaningful ways that warrant tailored public health interventions and clinical approaches.

With cannabis legalization continuing to expand and millions of Americans using marijuana for therapeutic reasons, the researchers say future studies should focus on improving education for both patients and healthcare providers, reducing stigma, and ensuring safe access for medical users.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

More articles from The Marijuana Herald can be found below.

Washington Bill Would Set Framework for Interstate Marijuana Commerce

Washington Bill Would Set Framework for Interstate Marijuana Commerce

Michigan Cannabis Sales Top $3.2 Billion in 2025 as Price Drops to All-Time Low of $58 Per Ounce

Michigan Cannabis Sales Top $3.2 Billion in 2025 as Price Drops to All-Time Low of $58 Per Ounce

Utah Bill Would Remove Criminal Penalties for First-Time Marijuana Possession of Up to 14 Grams, Reduce Penalties for Subsequent Offenses

Utah Bill Would Remove Criminal Penalties for First-Time Marijuana Possession of Up to 14 Grams, Reduce Penalties for Subsequent Offenses

Curaleaf Opens 160th U.S. Retail Location With New Medical Marijuana Dispensary in Florida

Curaleaf Opens 160th U.S. Retail Location With New Medical Marijuana Dispensary in Florida

Study: Cannabis-Infused Beverages Linked to Reduced Alcohol Use and Fewer Binge Drinking Episodes

Study: Cannabis-Infused Beverages Linked to Reduced Alcohol Use and Fewer Binge Drinking Episodes

West Virginia Lawmakers Propose Putting Marijuana Legalization Constitutional Amendment on 2026 Ballot

West Virginia Lawmakers Propose Putting Marijuana Legalization Constitutional Amendment on 2026 Ballot

Colorado Senate Bill Would Require Health Facilities to Allow Medical Marijuana Use by Terminally Ill Patients

Colorado Senate Bill Would Require Health Facilities to Allow Medical Marijuana Use by Terminally Ill Patients

West Virginia Bills Filed to Decriminalize Cannabis Possession, Protect Gun Rights for Medical Cannabis Patients

West Virginia Bills Filed to Decriminalize Cannabis Possession, Protect Gun Rights for Medical Cannabis Patients

Maryland Bill Would Direct Cannabis Tax Revenue to Veterans Trust Fund

Maryland Bill Would Direct Cannabis Tax Revenue to Veterans Trust Fund

Mississippi Senator Files Companion Bill to Decriminalize First-Time Marijuana Possession

Mississippi Senator Files Companion Bill to Decriminalize First-Time Marijuana Possession

Oklahoma Medical Marijuana Program Reports 319,965 Active Patients and 4,500 Licensed Businesses

Oklahoma Medical Marijuana Program Reports 319,965 Active Patients and 4,500 Licensed Businesses

Florida Medical Marijuana Program Reaches 740 Dispensaries

Florida Medical Marijuana Program Reaches 740 Dispensaries

Safe Harbor Expands Into Cannabis Insurance Through New Industry Partnerships

Safe Harbor Expands Into Cannabis Insurance Through New Industry Partnerships

Study: Psilocybin Treatment May Benefit Those With PTSD

Study: Psilocybin Treatment May Benefit Those With PTSD

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical